b'B e s t - i n - C l a s sA s s a y s & R e a g e n t sInvivoscribe provides a full range of standardized CE-marked in vitro diagnostic cGMP products for hematology-oncology, as well as RUO assays, analyte specific reagents (ASRs), and DNA & RNA controls.Next-Generation SequencingNGS is a powerful, high-throughput DNA sequencing technology that allows for massively parallel sequencing of millions of DNA fragments in a single sequencing run. NGS is revolutionizing modern science and healthcare.ABI Fluorescence DetectionWe exclusively offer a comprehensive selection of PCR-based assays for ABI fluorescence detection, including targeted FLT3 ITD and TKD mutation assays, B- and T-cell clonality assays (based on EuroClonality/BIOMED-2 Concerted Action BMH4-CT98-3936), and translocation assays.Gel DetectionWe exclusively offer a comprehensive selection of PCR-based assays for gel detection, including targeted FLT3 B e s t - i n - C l a s s ITD and TKD mutation assays, B- and T-cell clonality assays (based on EuroClonality/BIOMED-2 Concerted Action A s s a y s & R e a g e n t s BMH4-CT98-3936), and translocation assays.Controls & ReagentsInvivoscribe provides a full range of standardized CE-marked in vitro diagnosticInvivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) nucleic cGMP products for hematology-oncology, asacid controls.well as RUO assays, analyte specific reagentsCompanion Diagnostics (CDx)(ASRs), and DNA & RNA controls.Invivoscribe is a Comprehensive Partner for Companion Diagnostic Development.10Invivoscribe 2021|11'